Products for Research Use Only
RegisterLogin

Parimifasor

CAT: 0013-GTR19163460-01Size: 200 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19163460-01Size:200 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Parimifasor (LYC-30937-EC, LYC30937) is an orally bioavailable, enteric-coated ATPase modulator as a gut-directed therapy for the treatment of inflammatory bowel disease (IBD) .Psoriasis Phase 2 Clinical.
CAS Number
1796641-10-5
Product Name Alternative
LYC-30937-EC | LYC30937
Purity
>98% (HPLC)
Solubility
DMSO: ≥150 mg/mL (< 1 mg/ml refers to the product slightly soluble or insoluble)
Smiles
O=C (/N=C (NC1=CC (F) =CC (Cl) =C1) \NC2=NNC (C (F) (F) F) =C2) C3=CC=CC (Cl) =C3
Molecular Formula
C18H11Cl2F4N5O
Molecular Weight
460.214
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
3-chloro-N-[ (3-chloro-5-fluoroanilino) {[5- (trifluoromethyl) -1H-pyrazol-3-yl]amino}methylidene]benzamide

Alternative Products

CatalogName
MBS387317-01Parimifasor
A12594-10Parimifasor 10mg
A12594-100Parimifasor 100mg
A12594-50Parimifasor 50mg
A12594-25Parimifasor 25mg
A12594-5Parimifasor 5mg
A12594-2Parimifasor 2mg
A12594-1Parimifasor 1mg
A12594-10mM-DParimifasor 10mM * 1mL in DMSO

Popular Products